Cybin Inc. (NYSE AMERICAN: CYBN) Stock Information | RedChip

Cybin Inc. (NYSE AMERICAN: CYBN) Listen to this Section


$0.26
-0.0046 ( -1.74% ) 9.0M

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.

Market Data


Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
6-k Quarterly Reports 13 Aug 15, 2024
6-k Quarterly Reports 3 Aug 13, 2024
6-k Quarterly Reports 9 Aug 08, 2024
6-k Quarterly Reports 3 Aug 07, 2024
6-k Quarterly Reports 3 Jul 05, 2024
6-k/a Quarterly Reports 3 Jun 27, 2024
6-k Quarterly Reports 3 Jun 26, 2024
40-f Other 114 Jun 26, 2024
6-k Quarterly Reports 3 Jun 20, 2024
6-k Quarterly Reports 3 Jun 11, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.